Suppliers / Zhejiang Syncozymes Bio-pharmaceutical
Zhejiang Syncozymes Bio-pharmaceutical
China Updated 9 July 2026
Zhejiang Syncozymes Bio-pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 2 molecules. Its GMP standing is certified by MFDS (Korea).
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: FDA Establishment Registration, read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Shaoxing, China | Not on file |
| China, China | 3028704559 |
What they file, and where
| Molecule | Regulators | Docs |
| Quetiapine | EDQM, US FDA | 2 |
| Bupropion | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MFDS (Korea) | None | 2 |
Comparing suppliers?
Choose your molecules and target markets. Zhejiang Syncozymes Bio-pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates